BIOFILCHEM vs VIYASH: Stock Comparison

Biofil Chemicals & Pharmaceuticals Limited vs Viyash Scientific Ltd

Live data: 28 July 2026, 4:08 PM IST • Source: NSE and company filings

Viyash Scientific Ltd is the larger company by market capitalisation. Biofil Chemicals & Pharmaceuticals Limited shows a higher ROE, lower leverage and a higher net margin, while Viyash Scientific Ltd shows faster revenue growth and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Biofil Chemicals & Pharmaceuticals Limited and Viyash Scientific Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, BIOFILCHEM is more favourable on 4 of 11 scored metrics and VIYASH on 6These counts are context-free and are not an overall rating.

Key Differences

Market Cap
VIYASH is the larger company
₹11,038 Cr vs ₹53 Cr
EPS
VIYASH has higher earnings per share
₹4.06 vs ₹1.71
Revenue Growth (TTM YoY)
VIYASH has faster revenue growth
0% vs -9.3%
EPS Growth (TTM YoY)
BIOFILCHEM has faster EPS growth
10.8% vs 0%
Qtr Sales Growth
VIYASH has stronger quarterly sales growth
129% vs -9.34%
Qtr Profit Growth
VIYASH has stronger quarterly profit growth
455% vs 5%
ROE
BIOFILCHEM has a higher ROE
13.8% vs 11%
ROCE
VIYASH has a higher ROCE
19% vs 15.8%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBIOFILCHEMVIYASH
SectorHealthcare
IndustryPharmaceuticals

Price

MetricBIOFILCHEMVIYASH
Live Price₹32.64₹253.45
Day Change-0.55%-2.41%
Volume4,0489.28 L
52-Week High₹46.34₹298
52-Week Low₹25.6₹178.13
Distance from 52W High-29.56%-14.95%

Valuation

MetricBIOFILCHEMVIYASH
Market Cap₹53 Cr₹11,038 Cr
P/E Ratio62.48x
P/B Ratio3.81x
EPS₹1.71₹4.06
Book Value₹13.21₹66.6
Dividend Yield0%0%

Growth

MetricBIOFILCHEMVIYASH
Revenue Growth (TTM YoY)-9.3%0%
EPS Growth (TTM YoY)10.8%0%
Qtr Sales Growth-9.34%129%
Qtr Profit Growth5%455%

Profitability & Leverage

MetricBIOFILCHEMVIYASH
ROE13.8%11%
ROCE15.8%19%
Net Margin9.81%6.57%
Operating Margin2.29%19.1%
Debt to Equity0.14x0.17x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBIOFILCHEMVIYASH
Promoter Holding46.79%0%
FII Holding0%4.5% 1.56 pp
DII Holding0.08%3.75% 4.24 pp
Public Holding53.13%30.34% 2.67 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Biofil Chemicals & Pharmaceuticals Limited and Viyash Scientific Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.